These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 3091371)

  • 1. Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients.
    Talpaz M; Plager C; Quesada J; Benjamin R; Kantarjian H; Gutterman J
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):685-9. PubMed ID: 3091371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.
    Abeloff MD; Slavik M; Luk GD; Griffin CA; Hermann J; Blanc O; Sjoerdsma A; Baylin SB
    J Clin Oncol; 1984 Feb; 2(2):124-30. PubMed ID: 6422008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma.
    Meyskens FL; Kingsley EM; Glattke T; Loescher L; Booth A
    Invest New Drugs; 1986; 4(3):257-62. PubMed ID: 3102397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of alpha-difluoromethylornithine and methyl-GAG.
    Splinter TA; Romijn JC
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):61-7. PubMed ID: 3082642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma.
    Croghan MK; Booth A; Meyskens FL
    J Biol Response Mod; 1988 Aug; 7(4):409-15. PubMed ID: 3139843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.
    Abeloff MD; Rosen ST; Luk GD; Baylin SB; Zeltzman M; Sjoerdsma A
    Cancer Treat Rep; 1986 Jul; 70(7):843-5. PubMed ID: 3013400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
    Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD
    Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bis(guanylhydrazone)].
    Warrell RP; Coonley CJ; Burchenal JH
    Cancer Chemother Pharmacol; 1983; 11(2):134-6. PubMed ID: 6414731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD; Fleischmann J; Tackett RE; Ratliff TL
    Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I evaluation of intravenous difluoromethylornithine--a polyamine inhibitor.
    Maddox AM; Keating MJ; McCredie KE; Estey E; Freireich EJ
    Invest New Drugs; 1985; 3(3):287-92. PubMed ID: 3934106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon.
    Edmonson JH; Kovach JS; Buckner JC; Kvols LK; Hahn RG
    Cancer Res; 1988 Nov; 48(22):6584-6. PubMed ID: 3141046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.
    Mittelman A; Huberman M; Puccio C; Fallon B; Tessitore J; Savona S; Eyre R; Gafney E; Wick M; Skelos A
    Cancer; 1990 Aug; 66(4):664-9. PubMed ID: 2386896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.
    Love RR; Carbone PP; Verma AK; Gilmore D; Carey P; Tutsch KD; Pomplun M; Wilding G
    J Natl Cancer Inst; 1993 May; 85(9):732-7. PubMed ID: 8478959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mouse bladder tumor proliferation by alpha difluoromethylornithine and interferon in vitro and in vivo.
    Bahnson RR; Ratliff TL
    J Urol; 1988 Jun; 139(6):1367-71. PubMed ID: 3131549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
    Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
    Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
    Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II assessment of recombinant leukocyte A interferon with difluoromethylornithine in disseminated malignant melanoma.
    Creagan ET; Long HJ; Ahmann DL; Schaid DJ
    Am J Clin Oncol; 1990 Jun; 13(3):218-20. PubMed ID: 2111969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related alpha-difluoromethylornithine ototoxicity.
    Croghan MK; Aickin MG; Meyskens FL
    Am J Clin Oncol; 1991 Aug; 14(4):331-5. PubMed ID: 1862765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithine.
    Griffin CA; Slavik M; Chien SC; Hermann J; Thompson G; Blanc O; Luk GD; Baylin SB; Abeloff MD
    Invest New Drugs; 1987; 5(2):177-86. PubMed ID: 3115911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.